Ed Sheeran Apologizes Amid Controversy Over Gaza and Macklemore's Exclusion
Ed Sheeran opened his Philadelphia concert not with music, but with an apology for a difficult week, admitting to making tough decisions and mistakes. Visibly moved, Sheeran addressed the audience during his first show since the controversy erupted over rapper Macklemore's removal from the remaining dates of Sheeran's U.S. tour.
The dispute began when Macklemore expressed support for Palestinians during earlier tour dates in September, after which he was excluded from subsequent performances. Macklemore accused stadium officials of pressuring for his removal, while Sheeran had previously stated the decision was not his directly and that he had attempted to find a resolution with the involved parties.
On stage, Sheeran affirmed artists' right to express their views, stating he hadn't anticipated becoming central to a broad debate on free expression and artists' roles in public affairs. He also addressed the war in Gaza, describing the situation as "catastrophic and unjustified" and noting that civilians bear the brunt of conflicts. He also mentioned what he termed the injustice faced by Palestinians in the West Bank.
The controversy intensified recently with several artists withdrawing from opening slots on the tour in solidarity with Macklemore, including Lukas Graham, Aaron Rawe, and the band Beoga. Macklemore subsequently announced a $1 million donation to organizations supporting Palestinians.
Sheeran's remarks come as the Macklemore issue has evolved from a dispute over tour participation into a wider discussion within the music industry. This includes artists' withdrawals, donations linked to the Gaza humanitarian crisis, and ongoing reactions from artists and celebrities in the U.S. and abroad.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
